McMansions Define Ugly in a New Way: They’re a Bad Investment
http://www.bloomberg.com/news/articles/2016-08-23/mcmansions-define-ugly-in-a-new-way-they-re-a-bad-investment
http://www.bloomberg.com/news/articles/2016-08-23/mcmansions-define-ugly-in-a-new-way-they-re-a-bad-investment
http://www.bloomberg.com/news/articles/2016-08-23/the-workhorse-of-the-skies-is-being-put-out-to-pasture
http://www.reuters.com/article/us-dalianwanda-chairman-idUSKCN10Y13K
http://www.reuters.com/article/us-ubs-group-wealth-m-a-idUSKCN10Y1LD
Exclusive: China’s richest man set to seal two billion-dollar U.S. film deals U.N. rights chief deplores Gambia opposition detainee death Special Report: New massacre reports show U.S. inability to curb Iraq militias U.S. equity fund managers see reason to worry ahead of September VW, suppliers settle dispute after marathon talks Prevent Group, the supplier that…
Listen to Tuesday’s Investor’s Edge Radio Show: 8.23.2016 Click Here To Listen: https://archives.warpradio.com/btr/investorsedge/082318.mp3
Investor’s Edge: 08/23/2016
Stocks were quiet on Monday as oil prices fell by over -3%. In recent sessions, oil flirted with resistance near $50/barrel and is now pulling back a bit. In M&A news, Pfizer ($PFE) said it will acquire Medivation ($MDVN) for $81.50/share, or about $14 billion in cash. Medivation has one big cancer drug that attracted Pfizer to…